North Chemical Industries Co., Ltd. (SHE:002246)
China · Delayed Price · Currency is CNY 20.15
+0.35 (1.77%)
At close: Feb 13, 2026
North Chemical Industries Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,474 | 1,940 | 2,152 | 2,552 | 2,626 | 2,355 |
Other Revenue | 7.08 | 7.08 | 7.67 | 6.94 | 7.64 | 3.48 |
| 2,481 | 1,947 | 2,159 | 2,559 | 2,633 | 2,359 | |
Revenue Growth (YoY) | 25.42% | -9.83% | -15.61% | -2.84% | 11.66% | -4.15% |
Cost of Revenue | 1,811 | 1,600 | 1,710 | 2,091 | 2,132 | 1,906 |
Gross Profit | 670.64 | 347.33 | 449.64 | 467.23 | 501.86 | 452.52 |
Selling, General & Admin | 321.1 | 317.43 | 339.33 | 309.33 | 287.92 | 289.66 |
Research & Development | 129.91 | 115.55 | 83.1 | 117.19 | 110.36 | 94.21 |
Other Operating Expenses | 25.19 | 15.07 | 17.51 | 16.3 | 15.84 | 12.31 |
Operating Expenses | 484.52 | 455.68 | 461.95 | 439.33 | 415.58 | 395.34 |
Operating Income | 186.11 | -108.34 | -12.32 | 27.89 | 86.28 | 57.18 |
Interest Expense | -3.56 | -4.07 | -3.61 | -4.68 | -3.33 | - |
Interest & Investment Income | 27.79 | 32.12 | 36.66 | 35.34 | 37.1 | 24.93 |
Currency Exchange Gain (Loss) | 6.23 | 6.23 | 3.67 | 16.33 | -1.65 | -4.82 |
Other Non Operating Income (Expenses) | -7.8 | -0.7 | -0.62 | -0.66 | -0.57 | -0.14 |
EBT Excluding Unusual Items | 208.77 | -74.78 | 23.79 | 74.22 | 117.83 | 77.15 |
Gain (Loss) on Sale of Investments | 4.34 | 0.87 | - | - | - | - |
Gain (Loss) on Sale of Assets | -3.14 | 11.91 | -1.44 | -2.55 | 1.66 | -0.41 |
Asset Writedown | -1.62 | -2.64 | -1.93 | -0.02 | -45.14 | -5.78 |
Other Unusual Items | 31.07 | 31.07 | 28.36 | 23.52 | 33.33 | 26.41 |
Pretax Income | 239.42 | -33.57 | 48.78 | 95.16 | 107.69 | 97.36 |
Income Tax Expense | 40.98 | 1.89 | -3.65 | 6.03 | 11.52 | 15.77 |
Earnings From Continuing Operations | 198.43 | -35.45 | 52.43 | 89.13 | 96.17 | 81.6 |
Minority Interest in Earnings | 8.17 | 7.15 | 3.08 | 4.14 | 25.36 | 8.58 |
Net Income | 206.61 | -28.31 | 55.51 | 93.27 | 121.53 | 90.18 |
Net Income to Common | 206.61 | -28.31 | 55.51 | 93.27 | 121.53 | 90.18 |
Net Income Growth | - | - | -40.48% | -23.26% | 34.77% | -33.98% |
Shares Outstanding (Basic) | 566 | 566 | 555 | 549 | 552 | 564 |
Shares Outstanding (Diluted) | 566 | 566 | 555 | 549 | 552 | 564 |
Shares Change (YoY) | 1.97% | 1.98% | 1.19% | -0.69% | -1.99% | 3.16% |
EPS (Basic) | 0.36 | -0.05 | 0.10 | 0.17 | 0.22 | 0.16 |
EPS (Diluted) | 0.36 | -0.05 | 0.10 | 0.17 | 0.22 | 0.16 |
EPS Growth | - | - | -41.18% | -22.73% | 37.50% | -36.00% |
Free Cash Flow | 223.11 | 21.37 | -162.18 | -27.89 | 61.78 | 336.6 |
Free Cash Flow Per Share | 0.39 | 0.04 | -0.29 | -0.05 | 0.11 | 0.60 |
Dividend Per Share | 0.045 | 0.040 | 0.050 | 0.050 | 0.045 | 0.040 |
Dividend Growth | -35.71% | -20.00% | - | 11.11% | 12.50% | -27.27% |
Gross Margin | 27.03% | 17.84% | 20.82% | 18.26% | 19.06% | 19.19% |
Operating Margin | 7.50% | -5.56% | -0.57% | 1.09% | 3.28% | 2.42% |
Profit Margin | 8.33% | -1.45% | 2.57% | 3.65% | 4.61% | 3.82% |
Free Cash Flow Margin | 8.99% | 1.10% | -7.51% | -1.09% | 2.35% | 14.27% |
EBITDA | 303.7 | 3.94 | 92.91 | 121.43 | 183.58 | 152.49 |
EBITDA Margin | 12.24% | 0.20% | 4.30% | 4.75% | 6.97% | 6.46% |
D&A For EBITDA | 117.58 | 112.29 | 105.22 | 93.54 | 97.3 | 95.32 |
EBIT | 186.11 | -108.34 | -12.32 | 27.89 | 86.28 | 57.18 |
EBIT Margin | 7.50% | -5.56% | -0.57% | 1.09% | 3.28% | 2.42% |
Effective Tax Rate | 17.12% | - | - | 6.33% | 10.69% | 16.20% |
Revenue as Reported | 2,481 | 1,947 | 2,159 | 2,559 | 2,633 | 2,359 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.